ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,503Medicare Part D Prescriptions Filled, Including Refills

Rank: 8 out of 208

$1.03M Total Retail Price of All Prescriptions

Rank: 5 out of 208

548 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
50% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kentucky
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

19% of this provider’s 548 patients filled at least one prescription for a schedule three drug, compared to an average of 1%.

Risky Drugs to Seniors

1% of this provider’s 11,193 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$76 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 11.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kentucky
HYDROCODONE-ACETAMINOPHEN 721 583 S3 1 32
LEVOTHYROXINE SODIUM 484 417 2 31
METOPROLOL TARTRATE 469 368 3 2
LISINOPRIL 431 362 4 1
WARFARIN SODIUM 385 355 5 7
METOPROLOL SUCCINATE 366 318 6 4
PRAVASTATIN SODIUM 363 301 7 13
AMLODIPINE BESYLATE 346 290 8 5
CRESTOR 341 282 9 15
FUROSEMIDE 316 268 10 6
METFORMIN HCL 271 207 11 49
CLOPIDOGREL 237 196 12 8
GABAPENTIN 235 189 13 58
SIMVASTATIN 230 189 14 9
OMEPRAZOLE 216 184 15 28
ATORVASTATIN CALCIUM 207 178 16 11
DIOVAN 207 175 16 30
HYDRALAZINE HCL 197 170 18 35
PLAVIX 174 151 19 12
HYDROCHLOROTHIAZIDE 163 134 20 18
ISOSORBIDE MONONITRATE ER 160 127 21 10
LOSARTAN POTASSIUM 158 130 22 17
POTASSIUM CHLORIDE 156 126 23 19
ZOLPIDEM TARTRATE 154 131 24 81
NEXIUM 146 109 25 47
FENOFIBRATE 143 108 26 53
PANTOPRAZOLE SODIUM 140 128 27 42
LOVAZA 129 73 28 63
CLONIDINE HCL 126 113 29 39
ZETIA 119 88 30 34
CARVEDILOL 116 103 31 3
TRICOR 116 58 31 59
AZITHROMYCIN 113 84 33 100
SPIRONOLACTONE 109 91 34 21
ATENOLOL 107 92 35 16
RANITIDINE HCL 106 88 36 50
POLYETHYLENE GLYCOL 3350 101 91 37 99
DIGOXIN 99 91 38 14
TAMSULOSIN HCL 87 85 39 92
SPIRIVA 81 74 40 107
ALENDRONATE SODIUM 79 76 41 120
NITROSTAT 74 64 42 23
SERTRALINE HCL 73 55 43 88
TERAZOSIN HCL 71 71 44 188
RANEXA 69 46 45 22
DONEPEZIL HCL 68 68 46 93
PAROXETINE HCL 62 50 47 142
PROAIR HFA 61 57 48 98
ALLOPURINOL 61 57 48 76
DILTIAZEM 24HR CD 61 61 48 40
SINGULAIR 60 52 51 84
ROPINIROLE HCL 59 52 52 147
NICARDIPINE HCL 56 56 53 211
CIPROFLOXACIN HCL 55 47 54 129
ENALAPRIL MALEATE 55 49 54 62
CILOSTAZOL 55 52 54 56
DIOVAN HCT 53 44 57 70
JANUVIA 52 34 58 96
LEVOFLOXACIN 51 35 59 121
GLYBURIDE 50 38 R 60 160
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 15, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.